Faculty Research 1980 - 1989

Tin-protoporphyrin suppression of hyperbilirubinemia in mutant mice with severe hemolytic anemia.

Document Type


Publication Date



Animal, Dose-Response-Relationship-Drug, Heme-Oxygenase: me, Hyperbilirubinemia: dt, co, Kidney: en, Liver: en, Mice, Mice-Mutant-Strains, Porphyrins: tu, Protoporphyrins: tu, Spleen: en, SUPPORT-NON-U-S-GOVT, SUPPORT-U-S-GOVT-P-H-S

First Page


Last Page


JAX Source

Blood. 1983 May; 61(5):1011-3.


ES01055, HD00254, AM25305


Tin-protoporphyrin is a potent competitive inhibitor of heme oxygenase both in vivo in animals and in vitro in isolated enzyme preparations, and when administered to neonatal rats, prevents the development of postnatal hyperbilirubinemia. In this study we examined the effect of the metalloporphyrin on the activity of heme oxygenase in liver, kidney, and spleen, and on the level of bilirubin in plasma in three types of anemic mutant mice with severe hemolytic diseases. We report that the administration of tin-protoporphyrin to anemic mutants homozygous for severe hemolytic disease results in substantial inhibition of heme oxidation in liver, spleen, and kidney and in significant reduction of plasma bilirubin levels. Tin-protoporphyrin thus has the capacity to significantly inhibit in vivo heme degradation and to concurrently diminish plasma bilirubin levels in severe chronic hemolytic disorders.

Please contact the Joan Staats Library for information regarding this document.